As the burden of advanced lung diseases continues to rise, lung transplantation is emerging as a life-saving option for patients suffering from irreversible respiratory conditions who have exhausted all other treatment options.
Once considered a highly specialised procedure that was available only in select centres globally, Gurugram-based Medanta– TheMedicity -- ranked India’s best hospital by Newsweek in 2026 -- has played a pioneering role in advancing lung transplantation in our country. The hospital was the first to establish a lung transplant programme in North India and today reports a success rate of over 90%, offering comprehensive care for patients with end-stage lung diseases such as very severe Interstitial Lung Diseases (ILD), chronic obstructive pulmonary disease (COPD), cystic fibrosis, or pulmonary arterial hypertensionthrough a vastly experienced multidisciplinary team.Dr. Vivek Singh, Director, Respiratory & Sleep Medicine at Medanta Gurugram said, “A lung transplant should be considered when lung function declines to a stage where quality of life is severely compromised and life expectancy is limited without intervention.
With timely referral, careful patient selection and comprehensive post-transplant care, lung transplantation can restore mobility, independence and significantly improve survival. At Medanta, we have built an integrated ecosystem comprising transplant surgeons, pulmonologists, intensivists and rehabilitation specialists to deliver outcomes comparable to the best centres globally.
”He was speaking at a program in Amritsar, organized by Medanta in association with the Critical Care Society, Amritsar. Like all major transplants, lung transplantation carries certain risks, including organ rejection, infections due to long-term immunosuppressive therapy, blood clots and other post-operative complications. Dr. Singh said, “However, advances in surgical techniques, critical care and post-transplant monitoring have led to a steady improvement in outcomes over the past decade.”
